{"gene":"CD69","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1989,"finding":"CD69 cross-linking by mAb induces prolonged elevation of intracellular Ca2+ (mostly via extracellular Ca2+ influx); when PKC is simultaneously activated by PMA, CD69 stimulation drives IL-2 and IFN-γ gene expression, CD25 upregulation, and T cell proliferation; cyclosporin A abolishes these gene expression effects.","method":"mAb cross-linking of CD69 on human T cells, Ca2+ flux measurements, cytokine gene expression assays, pharmacological inhibitors (PMA, cyclosporin A)","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal functional assays with defined pharmacological controls, foundational mechanistic study","pmids":["2501389"],"is_preprint":false},{"year":1990,"finding":"CD69 is constitutively expressed on human platelets as a phosphorylated disulfide-linked homodimer; anti-CD69 mAb cross-linking induces platelet aggregation, Ca2+ influx, degranulation (ATP release), and production of thromboxane B2 and PGE2, indicating activation of arachidonic acid metabolism via cyclooxygenase.","method":"Biochemical characterization (SDS-PAGE), anti-CD69 mAb stimulation of platelets, Ca2+ influx assay, ATP release assay, thromboxane/PGE2 measurement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal assays with strong mechanistic readouts in a single study","pmids":["2388032"],"is_preprint":false},{"year":1992,"finding":"In neutrophils, CD69 is stored intracellularly (in a trans-Golgi structure, as brefeldin A does not block surface expression but cycloheximide does not inhibit either, since new synthesis is not required) and is rapidly mobilized to the cell surface upon PMA or fMLP activation independent of new protein synthesis; CD69 stimulation in neutrophils induces Ca2+ influx and enhances lysozyme release (granule exocytosis) via a Ca2+-dependent mechanism.","method":"Flow cytometry, cycloheximide and brefeldin A pharmacological inhibition, immunoprecipitation, Ca2+ influx assay, lysozyme release assay","journal":"Cellular immunology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple assays in single study, mechanistic conclusions supported by pharmacological inhibitors","pmids":["1586955"],"is_preprint":false},{"year":1993,"finding":"CD69 cDNA encodes a 199-amino-acid type II transmembrane protein with a C-type lectin-like extracellular domain; the gene maps to chromosome 12p13-p12; its mRNA is rapidly induced and degraded after lymphocyte stimulation due to 3' UTR degradation signals; transient expression of the CD69 cDNA in COS-7 cells reproduced native CD69 properties.","method":"PCR-based cDNA cloning, sequence analysis, COS-7 transient expression, somatic cell hybrid DNA analysis and FISH chromosomal mapping","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1 — direct molecular cloning with functional validation, highly cited foundational study","pmids":["8340758"],"is_preprint":false},{"year":1993,"finding":"CD69 expression is induced on thymocytes undergoing positive selection only when PKC-dependent signaling is engaged; PKC activator PMA induces CD69 on all thymocytes regardless of selecting MHC ligands, whereas TCR cross-linking induces CD69 only on thymocytes that have undergone or are undergoing positive selection.","method":"TCR-transgenic thymocyte cultures, anti-TCR antibody and PMA stimulation, flow cytometry","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — transgenic model plus pharmacological dissection, single study","pmids":["8095460"],"is_preprint":false},{"year":1994,"finding":"Constitutively active v-Ha-ras induces CD69 surface expression in Jurkat T cells, and dominant-negative c-Ha-ras-N17 suppresses TCR/CD3-mediated CD69 induction, demonstrating that p21ras activation is required for TCR-mediated CD69 expression.","method":"Transfection of constitutively active and dominant-negative ras constructs in Jurkat cells, flow cytometry, ras GTP-loading immunoprecipitation, AP-1-CAT reporter assay","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — gain-of-function and loss-of-function genetic approaches with biochemical validation","pmids":["7907294"],"is_preprint":false},{"year":1997,"finding":"CD69 gene expression is regulated by the transcription factor AP-1; stimuli that induce AP-1 but not NF-κB upregulate CD69 promoter activity, mRNA, and surface expression; a dominant-negative c-jun abolishes inducible CD69 transcription; an AP-1 binding site at position -16 of the CD69 promoter is transactivated by c-jun expression vectors.","method":"CD69 promoter-reporter transfection assays, EMSA, dominant-negative c-jun cotransfection, pharmacological inhibitors (pyrrolidine dithiocarbamate), IκB cotransfection","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (reporter assays, EMSA, dominant-negative), mechanistic dissection of promoter elements","pmids":["9580241"],"is_preprint":false},{"year":2000,"finding":"Crystal structure of the C-type lectin-like domain (NKD) of human CD69 was determined in two crystal forms; CD69 NKD adopts the canonical CTLD fold but lacks Ca2+ and carbohydrate binding features; it dimerizes noncovalently through a hydrophobic core with polar interactions including an interdomain β-sheet; a hydrophobic surface patch surrounded by conserved charged residues likely constitutes the ligand-binding site.","method":"X-ray crystallography (two crystal forms), solution dimerization analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure with functional interpretation of binding site","pmids":["11036086"],"is_preprint":false},{"year":2000,"finding":"CD69 engagement activates ERK (a MAPK family member), and this ERK activation is required for CD69-mediated cell degranulation in NK cells; co-engagement of the inhibitory receptor CD94/NKG2-A suppresses both CD69-triggered ERK activation and cell degranulation/cytotoxicity.","method":"RBL transfectants co-expressing CD69 and CD94/NKG2-A, ERK phosphorylation assays, degranulation assays, human NK cytotoxicity assays","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — reconstituted cell system plus primary NK cells, mechanistic inhibitor pathway","pmids":["10671222"],"is_preprint":false},{"year":2000,"finding":"The cytoplasmic domain of CD69 mediates Ca2+-dependent signaling (dependent on extracellular Ca2+ uptake) and TNF-α production; the neck region (Cys68) is critical for CD69 dimerization; domain swap chimeras between CD69 and CD23 showed that the cytoplasmic domain, not receptor oligomerization, determines the type of signal transduced.","method":"CD69/CD23 chimeric receptor domain-swapping, transfection in RBL-2H3 and Jurkat cells, Ca2+ flux assay, serotonin release assay, TNF-α measurement","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1 — domain-swapping mutagenesis with multiple functional readouts, mechanistic dissection","pmids":["11034393"],"is_preprint":false},{"year":2002,"finding":"CD69 cross-linking in IL-2-activated human NK cells rapidly activates Syk (but not ZAP70) in a Src family kinase (including Lck)-dependent manner; Syk and Src kinases then control tyrosine phosphorylation of PLCγ2 and the Rho GEF Vav1, and together regulate CD69-triggered NK cell cytotoxicity.","method":"Anti-CD69 mAb cross-linking, immunoprecipitation, tyrosine phosphorylation assays, kinase activity assays, pharmacological inhibitors, RBL transfectants stably expressing CD69","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple biochemical assays with defined signaling hierarchy in both primary NK cells and transfectants","pmids":["12077230"],"is_preprint":false},{"year":2002,"finding":"Constitutive overexpression of CD69 on T cells throughout development (CD69 transgenic mice) causes accumulation of phenotypically mature thymocytes in the medulla and failure of thymocyte export from the thymus, without affecting T cell maturation or TCR signaling, identifying a role for CD69 in controlling thymocyte egress.","method":"CD69 transgenic mouse generation, flow cytometry of thymic subsets, T cell maturation and selection analysis","journal":"International immunology","confidence":"High","confidence_rationale":"Tier 2 — transgenic mouse model with clear cellular phenotype, dose-dependent correlation with CD69 surface levels","pmids":["12039905"],"is_preprint":false},{"year":2003,"finding":"CD69-deficient mice show enhanced NK cell and T cell anti-tumor responses associated with increased MCP-1 chemokine production, decreased TGF-β production, and decreased lymphocyte apoptosis; CD69 engagement directly induces NK and T cell production of TGF-β, establishing a mechanistic link between CD69 signaling and TGF-β-mediated immunosuppression.","method":"CD69-/- mice tumor challenge, adoptive transfer, anti-CD69 antibody treatment in vivo, TGF-β production assays after CD69 engagement","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — knockout mouse model with defined cellular mechanism, direct in vitro mechanistic linkage replicated","pmids":["12732655"],"is_preprint":false},{"year":2007,"finding":"Phosphorylation of the actin-bundling protein L-plastin at Ser5 (induced by costimulation via TCR/CD3 plus CD2 or CD28) is required for transport of CD69 (and CD25) to the T cell surface; non-phosphorylatable 5A-L-plastin impairs surface expression of CD69 without affecting total CD69 protein levels.","method":"Mass spectrometry identification of phosphorylation site, site-directed mutagenesis of L-plastin (S5A), lentiviral expression in primary T cells, flow cytometry, immunological synapse imaging","journal":"European journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — mass spectrometry plus mutagenesis with clear functional readout, mechanistic dissection of surface transport","pmids":["17294403"],"is_preprint":false},{"year":2009,"finding":"CD69 gene transcription in T cells is regulated by evolutionarily conserved non-coding sequences (CNS1-4) upstream of the promoter; these elements function as inducible enhancers (CNS2, CNS4) or suppressors (CNS1, CNS2 together), and together with the promoter enable developmental-stage and lineage-specific regulation of CD69 in T but not B cells.","method":"DNase I hypersensitivity mapping, ChIP for histone modifications, transient transfection enhancer assays, transgenic reporter mice","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 1-2 — multiple complementary approaches (ChIP, transgenic mice, transient transfection), mechanistic dissection of cis-regulatory elements","pmids":["19841192"],"is_preprint":false},{"year":2010,"finding":"CD69 associates with S1P1 via its transmembrane and membrane-proximal domains (specifically requiring S1P1 transmembrane helix 4); this interaction suppresses S1P1 function, prolongs S1P binding half-life, and promotes S1P1 internalization and degradation, thereby retaining T cells in lymphoid tissues; a non-S1P1-binding CD69 mutant fails to inhibit T cell egress.","method":"Domain swap experiments between CD69 and NKRp1A, S1P1 mutagenesis (glycosylation, sulfation, desensitization motifs, TM helix 4), co-immunoprecipitation, S1P binding half-life assay, in vivo T cell egress assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — domain-mapping mutagenesis with biochemical and in vivo functional validation in a single rigorous study","pmids":["20463015"],"is_preprint":false},{"year":2010,"finding":"The cytoplasmic tail of CD69 associates with the Jak3/Stat5 signaling pathway; CD69 deficiency leads to impaired Jak3/Stat5 activity, reduced RORγt transcription inhibition, and consequently enhanced Th17 differentiation; selective Jak3 inhibition enhances RORγt transcription, and exogenous IL-2 restores Stat5 phosphorylation and suppresses enhanced Th17 differentiation in CD69-deficient cells.","method":"CD69-/- mouse T cell differentiation assays, biochemical co-immunoprecipitation of CD69 cytoplasmic tail with Jak3/Stat5, Stat5 phosphorylation assays, Jak3 inhibitor experiments, IL-2 rescue experiments, RORγt mRNA quantitation","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical interaction plus functional rescue experiments with multiple orthogonal readouts","pmids":["20696842"],"is_preprint":false},{"year":2012,"finding":"CD69-deficient effector CD4 T cells fail to relocate into and persist in the bone marrow, and consequently fail to differentiate into resting memory Th cells; this leads to defective generation of high-affinity antibodies and bone marrow long-lived plasma cells, establishing a role for CD69 in memory Th cell formation and bone marrow homing.","method":"CD69-/- mouse immunization models, flow cytometry of bone marrow T cell subsets, antibody affinity measurement, ELISPOT for plasma cells","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 2 — CD69-/- mouse model with multiple defined cellular and humoral immune readouts","pmids":["22474373"],"is_preprint":false},{"year":2014,"finding":"Galectin-1 on dendritic cells is a natural ligand for CD69; CD69 binds galectin-1 in a direct, carbohydrate-dependent interaction as confirmed by surface plasmon resonance and anti-CD69 blocking; this CD69-galectin-1 interaction mediates the negative effect of galectin-1 on Th17 differentiation in both human and mouse T cells.","method":"Recombinant CD69 extracellular domain pulldown on dendritic cells followed by mass spectrometry, surface plasmon resonance, anti-CD69 blocking assays, Th17 differentiation functional assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — pulldown-MS identification plus SPR binding characterization plus functional validation","pmids":["24752896"],"is_preprint":false},{"year":2015,"finding":"CD69 surface expression by skin-infiltrating CD8 T cells (regulated by local antigen stimulation and type I IFNR signaling) coincides with transcriptional downregulation of S1P1; CD69 expression, by interfering with S1P1 function, is a critical determinant of prolonged T cell retention and local TRM formation in skin.","method":"Skin-resident T cell transfer models, flow cytometry, transcriptional analysis of S1P1, in vivo T cell retention assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — in vivo mouse model with mechanistic pathway placement (CD69→S1P1 suppression→tissue retention)","pmids":["25624457"],"is_preprint":false},{"year":2015,"finding":"CD69 associates with the S100A8/S100A9 heterodimer (identified by co-immunoprecipitation and mass spectrometry); this interaction is glycosylation-dependent (N-linked glycans including sialic acid on CD69 are required); CD69-S100A8/S100A9 association upregulates SOCS3, thereby inhibiting STAT3 signaling and supporting TGF-β secretion and regulatory T cell differentiation.","method":"Immunoprecipitation and mass spectrometry, glycomics analysis of CD69, competition assay, PNGase F treatment, RNA interference, STAT3 signaling assays, Treg differentiation assays","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — multiple biochemical approaches in single lab; mechanistic pathway from ligand binding to signaling outcome","pmids":["26296369"],"is_preprint":false},{"year":2016,"finding":"CD69 associates with the aromatic amino acid transporter complex LAT1-CD98 (SLC7A5-SLC3A2) on the surface of γδ T cells and regulates its surface expression and L-tryptophan uptake; this controls intracellular L-Trp-derived AhR activators, leading to AhR-dependent IL-22 secretion and skin inflammation in psoriasis.","method":"Co-immunoprecipitation of CD69 with LAT1-CD98, flow cytometry of LAT1-CD98 surface expression in CD69-/- vs WT γδ T cells, L-Trp uptake assays, AhR inhibitor and IL-22 neutralization experiments, CD69-/- mouse IL-23-induced psoriasis model","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — co-IP interaction plus functional metabolic assay plus in vivo rescue experiments with multiple pharmacological agents","pmids":["27376471"],"is_preprint":false},{"year":2017,"finding":"HIF-1α directly transactivates the CD69 gene through a hypoxia response element (HRE) in the human CD69 locus; T cells in hypoxic conditions or hypoxic tumor microenvironments upregulate CD69 mRNA and protein in a HIF-1α-dependent manner.","method":"ChIP demonstrating HIF-1α binding to CD69 HRE, HIF-1α inducible knockout T cells, pimonidazole hypoxia labeling in vivo, quantitative RT-PCR and flow cytometry under hypoxia","journal":"Oncoimmunology","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP plus genetic HIF-1α KO validation plus in vivo hypoxia tracking","pmids":["28507790"],"is_preprint":false},{"year":2018,"finding":"CD69 overexpression in Tregs stimulates higher IL-10 production through STAT3 and STAT5 signaling pathways, with STAT3 directly binding the c-Maf promoter to drive c-Maf-dependent IL-10 expression; CD69+ Tregs but not CD69- Tregs or IL-10-deficient CD69+ Tregs prevent inflammatory bowel disease development after adoptive transfer.","method":"CD69 overexpression in Tregs, STAT3/STAT5 siRNA silencing, ChIP demonstrating STAT3 binding to c-Maf promoter, adoptive transfer into IBD mouse model, IL-10 ELISA","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus siRNA plus adoptive transfer, single lab study","pmids":["30185773"],"is_preprint":false},{"year":2018,"finding":"CD69 targeting with anti-CD69 mAb induces rapid mobilization of bone marrow leukocytes (including hematopoietic stem and progenitor cells) through S1P-dependent mechanisms (blocked by FTY720), and this mobilization is accompanied by increased mTOR/p70S6K/S6/4E-BP1 phosphorylation; mTOR inhibition with rapamycin blocks anti-CD69-induced HSPC mobilization.","method":"In vivo anti-CD69 mAb treatment, FTY720 blockade, AMD3100 comparison, flow cytometry of HSPC subsets, phosphorylation assays of mTOR pathway components, rapamycin inhibition","journal":"Leukemia","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo mouse model with pharmacological dissection of S1P and mTOR pathways, single lab","pmids":["29483712"],"is_preprint":false},{"year":2022,"finding":"CD69 expression on Tregs promotes AhR-dependent CD39 ectonucleotidase activity, which induces apoptosis of γδ T cells and decreases their IL-17A production; in CD69-/- mice after myocardial infarction, enhanced IL-17+ γδT cell responses worsen cardiac function; adoptive transfer of CD69+ Tregs into CD69-/- mice reduces IL-17+ γδT cell recruitment and increases survival.","method":"Cd69-/- mouse LAD ligation model, AhR inhibitor experiments, adoptive transfer of CD69+ Tregs, flow cytometry, CD39 ectonucleotidase activity assays, apoptosis assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1-2 — knockout mouse model with mechanistic pathway (CD69→AhR→CD39→γδT apoptosis) validated by adoptive transfer and enzyme activity assays","pmids":["36066993"],"is_preprint":false},{"year":2023,"finding":"Cryo-EM structure of CD69-bound S1PR1 coupled to heterotrimeric Gi reveals that the transmembrane helix of one CD69 homodimer protomer contacts S1PR1-TM4; this interaction allosterically induces movement of S1PR1-TM5-6, directly activating the receptor and engaging Gi; CD69 thus acts as a protein agonist (in cis) of S1PR1, promoting Gi-dependent S1PR1 internalization, loss of S1P gradient sensing, and inhibition of lymphocyte egress. Key interface mutations reduce CD69-S1PR1 interaction and receptor internalization.","method":"Cryo-EM structure determination of CD69-S1PR1-Gi complex, mutagenesis of interface residues, receptor internalization assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with mutagenesis and functional validation, definitive mechanism","pmids":["37039481"],"is_preprint":false},{"year":2005,"finding":"CD69 associates with an N-terminal fragment of calreticulin expressed at the surface of human PBMCs, as identified by co-immunoprecipitation followed by direct protein sequencing (LC/MS/MS).","method":"Co-immunoprecipitation and LC/MS/MS protein sequencing from primary human PBMCs","journal":"Archives of biochemistry and biophysics","confidence":"Low","confidence_rationale":"Tier 3 — single co-IP/MS identification without functional follow-up validation","pmids":["15893733"],"is_preprint":false}],"current_model":"CD69 is a type II C-type lectin-like homodimeric receptor (crystal/cryo-EM structure resolved) that, upon activation, signals through PKC→Ras→ERK and Src→Syk→PLCγ2/Vav1 pathways to drive Ca2+ influx, cytokine gene expression (IL-2, IFN-γ, TNF-α), and TGF-β production; its cytoplasmic tail associates with Jak3/Stat5 to suppress Th17 differentiation; it physically associates in cis with S1PR1 (via TM helix contacts) to act as a GPCR protein agonist that drives Gi-dependent S1PR1 internalization and degradation, thereby retaining lymphocytes in tissues; it also associates with the amino acid transporter LAT1-CD98 to regulate L-tryptophan uptake and AhR-dependent IL-22 secretion, and binds extracellular ligands galectin-1 and S100A8/S100A9 to modulate Th17 and Treg differentiation respectively; HIF-1α directly transactivates CD69 transcription through an HRE, while AP-1 and NF-κB regulate its promoter, and L-plastin phosphorylation controls CD69 surface transport."},"narrative":{"teleology":[{"year":1989,"claim":"Establishing that CD69 is a signaling receptor: cross-linking demonstrated that CD69 transduces Ca²⁺ influx and, when PKC is co-activated, drives cytokine gene expression (IL-2, IFN-γ) in a calcineurin-dependent manner, defining it as a functional activating receptor on T cells.","evidence":"Anti-CD69 mAb cross-linking on human T cells with Ca²⁺ flux measurement, cytokine assays, and cyclosporin A inhibition","pmids":["2501389"],"confidence":"High","gaps":["Proximal signaling intermediates downstream of cross-linking were not identified","Whether CD69 signals autonomously or requires co-receptors was unresolved"]},{"year":1990,"claim":"Extending CD69 function beyond lymphocytes: CD69 was shown to be constitutively expressed on platelets as a disulfide-linked homodimer, where its cross-linking induced aggregation, Ca²⁺ influx, degranulation, and arachidonic acid metabolite production, establishing it as a functional activating receptor in non-lymphoid hematopoietic cells.","evidence":"Anti-CD69 mAb stimulation of human platelets with SDS-PAGE, Ca²⁺ flux, ATP release, and thromboxane/PGE2 measurement","pmids":["2388032"],"confidence":"High","gaps":["Platelet CD69 ligand identity was unknown","Whether intracellular signaling pathways differ from lymphocytes was not tested"]},{"year":1993,"claim":"Defining CD69 molecular identity and linking its induction to positive selection: cDNA cloning revealed a 199-aa type II transmembrane protein with a C-type lectin-like domain on chromosome 12p; concurrently, CD69 induction during thymic selection was shown to require PKC-dependent signaling.","evidence":"PCR-based cDNA cloning with COS-7 expression; TCR-transgenic thymocyte stimulation with PMA and anti-TCR, flow cytometry","pmids":["8340758","8095460"],"confidence":"High","gaps":["Whether CD69 is functionally required for selection or merely a marker was unclear","No structural data on the lectin domain"]},{"year":1994,"claim":"Placing Ras in the TCR-to-CD69 signaling axis: constitutively active v-Ha-ras induced CD69, while dominant-negative ras blocked TCR-mediated CD69 expression, establishing p21ras as an essential node upstream of CD69 transcription.","evidence":"Gain- and loss-of-function ras constructs in Jurkat cells, flow cytometry, ras GTP-loading assays","pmids":["7907294"],"confidence":"High","gaps":["Downstream transcription factors linking ras to CD69 promoter were not identified in this study"]},{"year":1997,"claim":"Identifying AP-1 as a direct transcriptional regulator of CD69: an AP-1 site at position −16 in the CD69 promoter was shown to be transactivated by c-Jun, and dominant-negative c-Jun abolished inducible CD69 transcription, connecting the Ras/MAPK pathway to CD69 gene expression.","evidence":"CD69 promoter-reporter assays, EMSA, dominant-negative c-Jun cotransfection in T cells","pmids":["9580241"],"confidence":"High","gaps":["Contribution of NF-κB sites to CD69 promoter regulation under other conditions was not fully resolved","Chromatin context was not addressed"]},{"year":2000,"claim":"Resolving the structural basis of the CD69 ectodomain and dissecting signaling domains: crystal structure showed the CTLD fold lacks canonical Ca²⁺/carbohydrate-binding features; concurrently, domain-swap chimeras demonstrated that the cytoplasmic tail (not receptor oligomerization) determines signaling output, while ERK activation was identified as required for CD69-mediated NK cell degranulation.","evidence":"X-ray crystallography of CD69 CTLD; CD69/CD23 chimeric receptors in RBL/Jurkat cells; ERK phosphorylation and degranulation assays in NK cells","pmids":["11036086","11034393","10671222"],"confidence":"High","gaps":["Natural ligand identity remained unknown","How the short cytoplasmic tail engages signaling mediators was not determined"]},{"year":2002,"claim":"Defining the proximal signaling cascade and revealing a role in thymocyte egress: Src-family kinase–dependent Syk activation (not ZAP70) was identified as the proximal pathway linking CD69 cross-linking to PLCγ2/Vav1 phosphorylation and NK cytotoxicity; simultaneously, CD69 transgenic mice showed that constitutive CD69 expression blocks thymocyte export without affecting maturation.","evidence":"Anti-CD69 mAb cross-linking with kinase assays and pharmacological inhibitors in NK cells; CD69-transgenic mouse thymic analysis","pmids":["12077230","12039905"],"confidence":"High","gaps":["Molecular mechanism by which CD69 blocks egress was unknown","Whether Syk activation occurs in T cells as well as NK cells was not shown"]},{"year":2003,"claim":"Establishing CD69 as an immunosuppressive regulator through TGF-β: CD69-deficient mice showed enhanced anti-tumor immunity due to reduced TGF-β production and increased MCP-1; direct CD69 engagement induced TGF-β secretion by NK and T cells, revealing an immunoregulatory signaling output.","evidence":"CD69−/− mice tumor challenge, adoptive transfer, in vitro CD69 engagement with TGF-β measurement","pmids":["12732655"],"confidence":"High","gaps":["Whether TGF-β induction requires specific signaling intermediates was not resolved","Identity of endogenous CD69 ligand triggering TGF-β remained unknown"]},{"year":2007,"claim":"Identifying a cytoskeletal checkpoint for CD69 surface delivery: L-plastin phosphorylation at Ser5 was required for CD69 transport to the T cell surface, revealing post-translational control of CD69 surface expression independent of transcription.","evidence":"Mass spectrometry of L-plastin phosphorylation, S5A mutagenesis, lentiviral expression in primary T cells, flow cytometry","pmids":["17294403"],"confidence":"High","gaps":["Whether L-plastin directly binds CD69-containing vesicles or acts indirectly through actin remodeling was not determined"]},{"year":2010,"claim":"Solving the molecular mechanism of lymphocyte tissue retention: CD69 was shown to associate with S1PR1 via transmembrane contacts (requiring S1PR1-TM4), promoting S1PR1 internalization and degradation; simultaneously, CD69's cytoplasmic tail was found to engage Jak3/Stat5, suppressing RORγt and Th17 differentiation.","evidence":"Domain-swap and TM4 mutagenesis with co-IP and in vivo egress assays; CD69−/− T cell Jak3/Stat5 biochemistry with IL-2 rescue","pmids":["20463015","20696842"],"confidence":"High","gaps":["Atomic-resolution structure of the CD69–S1PR1 interface was lacking","Whether Jak3/Stat5 association is direct or mediated by an adaptor was not resolved"]},{"year":2014,"claim":"Identifying the first natural extracellular ligands: galectin-1 on dendritic cells was identified as a carbohydrate-dependent CD69 ligand that mediates suppression of Th17 differentiation, establishing a receptor-ligand axis for CD69's immunomodulatory function.","evidence":"Recombinant CD69 pulldown from DCs followed by mass spectrometry, SPR binding, blocking antibodies, Th17 differentiation assays","pmids":["24752896"],"confidence":"High","gaps":["Binding affinity and stoichiometry were not fully characterized","Whether galectin-1 binding triggers the same intracellular pathways as antibody cross-linking was not tested"]},{"year":2015,"claim":"Extending the ligand repertoire and demonstrating tissue-resident memory formation: S100A8/S100A9 was identified as a glycosylation-dependent CD69 ligand that signals via SOCS3/STAT3 to promote Treg differentiation; CD69 expression on skin CD8 T cells was shown to be essential for tissue-resident memory (TRM) formation via S1PR1 suppression.","evidence":"Co-IP/MS identification of S100A8/S100A9, glycomics, STAT3 signaling assays; skin T cell transfer with S1PR1 transcriptional analysis","pmids":["26296369","25624457"],"confidence":"High","gaps":["Structural basis of glycan-dependent S100A8/S100A9 binding was unknown","Whether S100A8/S100A9 and galectin-1 compete for the same binding site was not addressed"]},{"year":2016,"claim":"Revealing a metabolic function: CD69 was found to associate with the LAT1-CD98 amino acid transporter, controlling its surface expression and L-tryptophan uptake, which feeds AhR activation and IL-22 secretion in γδ T cells driving psoriatic inflammation.","evidence":"Co-IP of CD69 with LAT1-CD98, L-Trp uptake assays in CD69−/− vs WT γδ T cells, AhR inhibitor and IL-22 neutralization, CD69−/− psoriasis model","pmids":["27376471"],"confidence":"High","gaps":["Whether CD69–LAT1 interaction is direct or mediated by CD98 was not determined","Relevance beyond γδ T cells was not established"]},{"year":2017,"claim":"Adding hypoxia-responsive transcriptional control: HIF-1α was shown to directly transactivate CD69 through an HRE, explaining CD69 upregulation in hypoxic tumor microenvironments and providing a mechanism for hypoxia-driven lymphocyte tissue retention.","evidence":"ChIP for HIF-1α at CD69 HRE, conditional HIF-1α knockout T cells, pimonidazole labeling in vivo","pmids":["28507790"],"confidence":"High","gaps":["Relative contribution of HIF-1α vs AP-1 in tumor contexts was not quantified","Whether HIF-1α-induced CD69 mediates S1PR1 internalization specifically in tumors was not tested"]},{"year":2022,"claim":"Connecting CD69 to ectonucleotidase-mediated immunosuppression: CD69 on Tregs was shown to promote AhR-dependent CD39 activity, inducing γδ T cell apoptosis and reducing IL-17A production; this pathway is cardioprotective after myocardial infarction.","evidence":"CD69−/− mouse LAD ligation, AhR inhibitor, adoptive transfer of CD69+ Tregs, CD39 activity assays, apoptosis assays","pmids":["36066993"],"confidence":"High","gaps":["Whether CD69 directly activates AhR or acts through tryptophan metabolite changes was not distinguished","Relevance to other tissue injury models was not tested"]},{"year":2023,"claim":"Providing atomic-resolution proof that CD69 is a GPCR protein agonist: cryo-EM of the CD69–S1PR1–Gi complex revealed that one CD69 TM helix contacts S1PR1-TM4, allosterically displacing TM5-6 to activate Gi coupling, definitively establishing the structural mechanism of CD69-mediated S1PR1 internalization and lymphocyte retention.","evidence":"Cryo-EM structure determination of CD69–S1PR1–Gi ternary complex, interface mutagenesis, receptor internalization assays","pmids":["37039481"],"confidence":"High","gaps":["Whether the second CD69 protomer in the homodimer can simultaneously engage another S1PR1 molecule is unknown","The structure was obtained in detergent — lipid bilayer effects on the interface remain untested"]},{"year":null,"claim":"Key unresolved questions include whether CD69's multiple cis-membrane partners (S1PR1, LAT1-CD98) can be simultaneously engaged, how the short cytoplasmic tail recruits both Jak3/Stat5 and Syk/PLCγ2 pathways in different cell types, and whether additional physiological soluble ligands exist beyond galectin-1 and S100A8/S100A9.","evidence":"","pmids":[],"confidence":"Low","gaps":["No reconstitution of simultaneous CD69–S1PR1 and CD69–LAT1 complexes","Structural basis of cytoplasmic tail signaling selectivity is unknown","Comprehensive ligand screening has not been performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[15,16,26]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,9,10]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[21,16]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,3,13,21]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,10,12,16,18,21,25]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[5,8,15,16,26]},{"term_id":"R-HSA-109582","term_label":"Hemostasis","supporting_discovery_ids":[1]}],"complexes":["CD69 homodimer","CD69-S1PR1-Gi complex"],"partners":["S1PR1","LGALS1","S100A8","S100A9","SLC7A5","SLC3A2","JAK3","SYK"],"other_free_text":[]},"mechanistic_narrative":"CD69 is a type II C-type lectin-like homodimeric receptor that functions as a central regulator of lymphocyte tissue retention, activation signaling, and immunomodulatory cytokine production. Structurally, CD69 dimerizes through its extracellular C-type lectin-like domain and uses its transmembrane helix to engage S1PR1 in cis, acting as a protein agonist that activates Gi-coupled S1PR1 internalization and degradation, thereby abolishing S1P-directed lymphocyte egress and enforcing tissue residency [PMID:20463015, PMID:37039481]. Upon cross-linking, CD69 signals through its cytoplasmic tail via Src→Syk→PLCγ2/Vav1 and Ras→ERK pathways to drive Ca²⁺ influx, cytokine gene expression (IL-2, IFN-γ, TNF-α), and TGF-β production, while also associating with Jak3/Stat5 to suppress Th17 differentiation by inhibiting RORγt transcription [PMID:2501389, PMID:12077230, PMID:20696842, PMID:12732655]. CD69 additionally interacts with extracellular ligands galectin-1 and S100A8/S100A9 to regulate Th17 and Treg differentiation, and associates with the LAT1-CD98 amino acid transporter to control L-tryptophan uptake and AhR-dependent IL-22 secretion [PMID:24752896, PMID:26296369, PMID:27376471]."},"prefetch_data":{"uniprot":{"accession":"Q07108","full_name":"Early activation antigen CD69","aliases":["Activation inducer molecule","AIM","BL-AC/P26","C-type lectin domain family 2 member C","EA1","Early T-cell activation antigen p60","GP32/28","Leukocyte surface antigen Leu-23","MLR-3"],"length_aa":199,"mass_kda":22.6,"function":"Transmembrane protein expressed mainly on T-cells resident in mucosa that plays an essential role in immune cell homeostasis. Rapidly expressed on the surface of platelets, T-lymphocytes and NK cells upon activation by various stimuli, such as antigen recognition or cytokine signaling, stimulates different signaling pathways in different cell types (PubMed:24752896, PubMed:26296369, PubMed:35930205). Negatively regulates Th17 cell differentiation through its carbohydrate dependent interaction with galectin-1/LGALS1 present on immature dendritic cells (PubMed:24752896). Association of CD69 cytoplasmic tail with the JAK3/STAT5 signaling pathway regulates the transcription of RORgamma/RORC and, consequently, differentiation toward the Th17 lineage (By similarity). Also acts via the S100A8/S100A9 complex present on peripheral blood mononuclear cells to promote the conversion of naive CD4 T-cells into regulatory T-cells (PubMed:26296369). Acts as an oxidized low-density lipoprotein (oxLDL) receptor in CD4 T-lymphocytes and negatively regulates the inflammatory response by inducing the expression of PDCD1 through the activation of NFAT (PubMed:35930205). Participates in adipose tissue-derived mesenchymal stem cells (ASCs)-mediated protection against P.aeruginosa infection. Mechanistically, specifically recognizes P.aeruginosa to promote ERK1 activation, followed by granulocyte-macrophage colony-stimulating factor (GM-CSF) and other inflammatory cytokines secretion (PubMed:34841721). In eosinophils, induces IL-10 production through the ERK1/2 pathway (By similarity). Negatively regulates the chemotactic responses of effector lymphocytes and dendritic cells (DCs) to sphingosine 1 phosphate/S1P by acting as a S1PR1 receptor agonist and facilitating the internalization and degradation of the receptor (PubMed:37039481)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q07108/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CD69","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CD69","total_profiled":1310},"omim":[{"mim_id":"619374","title":"IMMUNODEFICIENCY 81; IMD81","url":"https://www.omim.org/entry/619374"},{"mim_id":"618307","title":"IMMUNODEFICIENCY 129; IMD129","url":"https://www.omim.org/entry/618307"},{"mim_id":"618306","title":"PROLINE-RICH PROTEIN 7; PRR7","url":"https://www.omim.org/entry/618306"},{"mim_id":"617514","title":"IMMUNODEFICIENCY 52; IMD52","url":"https://www.omim.org/entry/617514"},{"mim_id":"612087","title":"C-TYPE LECTIN DOMAIN FAMILY 2, MEMBER A; CLEC2A","url":"https://www.omim.org/entry/612087"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"bone marrow","ntpm":159.6},{"tissue":"lymphoid tissue","ntpm":88.3}],"url":"https://www.proteinatlas.org/search/CD69"},"hgnc":{"alias_symbol":["CLEC2C"],"prev_symbol":[]},"alphafold":{"accession":"Q07108","domains":[{"cath_id":"3.10.100.10","chopping":"89-196","consensus_level":"high","plddt":98.0181,"start":89,"end":196}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07108","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q07108-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q07108-F1-predicted_aligned_error_v6.png","plddt_mean":82.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CD69","jax_strain_url":"https://www.jax.org/strain/search?query=CD69"},"sequence":{"accession":"Q07108","fasta_url":"https://rest.uniprot.org/uniprotkb/Q07108.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q07108/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q07108"}},"corpus_meta":[{"pmid":"28475283","id":"PMC_28475283","title":"CD69: from activation marker to metabolic gatekeeper.","date":"2017","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/28475283","citation_count":730,"is_preprint":false},{"pmid":"7804122","id":"PMC_7804122","title":"The activation antigen CD69.","date":"1994","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/7804122","citation_count":453,"is_preprint":false},{"pmid":"25624457","id":"PMC_25624457","title":"Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25624457","citation_count":428,"is_preprint":false},{"pmid":"7945773","id":"PMC_7945773","title":"The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells.","date":"1994","source":"Immunology today","url":"https://pubmed.ncbi.nlm.nih.gov/7945773","citation_count":396,"is_preprint":false},{"pmid":"2501389","id":"PMC_2501389","title":"T cell activation via Leu-23 (CD69).","date":"1989","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/2501389","citation_count":266,"is_preprint":false},{"pmid":"8340758","id":"PMC_8340758","title":"Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors.","date":"1993","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/8340758","citation_count":263,"is_preprint":false},{"pmid":"8095460","id":"PMC_8095460","title":"CD69 expression during selection and maturation of CD4+8+ thymocytes.","date":"1993","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8095460","citation_count":250,"is_preprint":false},{"pmid":"20463015","id":"PMC_20463015","title":"CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20463015","citation_count":249,"is_preprint":false},{"pmid":"10515800","id":"PMC_10515800","title":"Early CD69 expression on peripheral blood lymphocytes from children with dengue hemorrhagic fever.","date":"1999","source":"The Journal of infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/10515800","citation_count":161,"is_preprint":false},{"pmid":"8262555","id":"PMC_8262555","title":"CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.","date":"1993","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/8262555","citation_count":139,"is_preprint":false},{"pmid":"12732655","id":"PMC_12732655","title":"Enhanced antitumor immunity in mice deficient in CD69.","date":"2003","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12732655","citation_count":138,"is_preprint":false},{"pmid":"7907294","id":"PMC_7907294","title":"Involvement of p21ras activation in T cell CD69 expression.","date":"1994","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7907294","citation_count":127,"is_preprint":false},{"pmid":"12039905","id":"PMC_12039905","title":"A potential role for CD69 in thymocyte emigration.","date":"2002","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12039905","citation_count":125,"is_preprint":false},{"pmid":"22474373","id":"PMC_22474373","title":"Type II membrane protein CD69 regulates the formation of resting T-helper memory.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22474373","citation_count":117,"is_preprint":false},{"pmid":"20696842","id":"PMC_20696842","title":"CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20696842","citation_count":111,"is_preprint":false},{"pmid":"2388032","id":"PMC_2388032","title":"CD69 is expressed on platelets and mediates platelet activation and aggregation.","date":"1990","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/2388032","citation_count":104,"is_preprint":false},{"pmid":"27376471","id":"PMC_27376471","title":"CD69 controls the uptake of L-tryptophan through LAT1-CD98 and AhR-dependent secretion of IL-22 in psoriasis.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27376471","citation_count":101,"is_preprint":false},{"pmid":"30185773","id":"PMC_30185773","title":"CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 production.","date":"2018","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/30185773","citation_count":92,"is_preprint":false},{"pmid":"17294403","id":"PMC_17294403","title":"Costimulation induced phosphorylation of L-plastin facilitates surface transport of the T cell activation molecules CD69 and CD25.","date":"2007","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17294403","citation_count":89,"is_preprint":false},{"pmid":"10733501","id":"PMC_10733501","title":"Phenotypic and functional characteristics of hematopoietic cell lineages in CD69-deficient mice.","date":"2000","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/10733501","citation_count":88,"is_preprint":false},{"pmid":"9580241","id":"PMC_9580241","title":"Expression of the leukocyte early activation antigen CD69 is regulated by the transcription factor AP-1.","date":"1997","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9580241","citation_count":86,"is_preprint":false},{"pmid":"24752896","id":"PMC_24752896","title":"The leukocyte activation receptor CD69 controls T cell differentiation through its interaction with galectin-1.","date":"2014","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24752896","citation_count":83,"is_preprint":false},{"pmid":"9448032","id":"PMC_9448032","title":"Temporal dynamics of CD69 expression on lymphoid cells.","date":"1997","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/9448032","citation_count":83,"is_preprint":false},{"pmid":"9618391","id":"PMC_9618391","title":"CD44 and CD69 represent different types of cell-surface activation markers for human eosinophils.","date":"1998","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/9618391","citation_count":81,"is_preprint":false},{"pmid":"24934597","id":"PMC_24934597","title":"Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression.","date":"2014","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/24934597","citation_count":79,"is_preprint":false},{"pmid":"27226093","id":"PMC_27226093","title":"Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population.","date":"2016","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/27226093","citation_count":78,"is_preprint":false},{"pmid":"30085193","id":"PMC_30085193","title":"Crucial role of CD69 in anti-tumor immunity through regulating the exhaustion of tumor-infiltrating T cells.","date":"2018","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30085193","citation_count":78,"is_preprint":false},{"pmid":"10357208","id":"PMC_10357208","title":"Brefeldin A, but not monensin, completely blocks CD69 expression on mouse lymphocytes: efficacy of inhibitors of protein secretion in protocols for intracellular cytokine staining by flow cytometry.","date":"1999","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/10357208","citation_count":73,"is_preprint":false},{"pmid":"8639899","id":"PMC_8639899","title":"Ligation of CD69 induces apoptosis and cell death in human eosinophils cultured with granulocyte-macrophage colony-stimulating factor.","date":"1996","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/8639899","citation_count":72,"is_preprint":false},{"pmid":"11036086","id":"PMC_11036086","title":"Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11036086","citation_count":70,"is_preprint":false},{"pmid":"26296369","id":"PMC_26296369","title":"Glycosylation-dependent interaction between CD69 and S100A8/S100A9 complex is required for regulatory T-cell differentiation.","date":"2015","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/26296369","citation_count":65,"is_preprint":false},{"pmid":"1586955","id":"PMC_1586955","title":"CD69 molecule in human neutrophils: its expression and role in signal-transducing mechanisms.","date":"1992","source":"Cellular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1586955","citation_count":64,"is_preprint":false},{"pmid":"20621339","id":"PMC_20621339","title":"The leukocyte activation antigen CD69 limits allergic asthma and skin contact hypersensitivity.","date":"2010","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/20621339","citation_count":63,"is_preprint":false},{"pmid":"33554350","id":"PMC_33554350","title":"The Clinical Significance of Hepatic CD69+ CD103+ CD8+ Resident-Memory T Cells in Autoimmune Hepatitis.","date":"2021","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/33554350","citation_count":60,"is_preprint":false},{"pmid":"10671222","id":"PMC_10671222","title":"CD69-triggered ERK activation and functions are negatively regulated by CD94 / NKG2-A inhibitory receptor.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10671222","citation_count":59,"is_preprint":false},{"pmid":"10201918","id":"PMC_10201918","title":"CD69 expression discriminates MHC-dependent and -independent stages of thymocyte positive selection.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10201918","citation_count":58,"is_preprint":false},{"pmid":"8323399","id":"PMC_8323399","title":"Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis.","date":"1993","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/8323399","citation_count":57,"is_preprint":false},{"pmid":"11994706","id":"PMC_11994706","title":"Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3.","date":"2002","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11994706","citation_count":55,"is_preprint":false},{"pmid":"10898494","id":"PMC_10898494","title":"Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation.","date":"2000","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10898494","citation_count":54,"is_preprint":false},{"pmid":"15692061","id":"PMC_15692061","title":"Induction of tumor NK-cell immunity by anti-CD69 antibody therapy.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/15692061","citation_count":53,"is_preprint":false},{"pmid":"21427408","id":"PMC_21427408","title":"CD69: an unexpected regulator of TH17 cell-driven inflammatory responses.","date":"2011","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/21427408","citation_count":49,"is_preprint":false},{"pmid":"17107954","id":"PMC_17107954","title":"Phosphorylation of the LFA-1 integrin beta2-chain on Thr-758 leads to adhesion, Rac-1/Cdc42 activation, and stimulation of CD69 expression in human T cells.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17107954","citation_count":49,"is_preprint":false},{"pmid":"26100786","id":"PMC_26100786","title":"Levels of regulatory T cells CD69(+)NKG2D(+)IL-10(+) are increased in patients with autoimmune thyroid disorders.","date":"2015","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/26100786","citation_count":48,"is_preprint":false},{"pmid":"21777379","id":"PMC_21777379","title":"Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.","date":"2012","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21777379","citation_count":48,"is_preprint":false},{"pmid":"16342326","id":"PMC_16342326","title":"CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.","date":"2006","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16342326","citation_count":47,"is_preprint":false},{"pmid":"19841192","id":"PMC_19841192","title":"CD69 gene is differentially regulated in T and B cells by evolutionarily conserved promoter-distal elements.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19841192","citation_count":46,"is_preprint":false},{"pmid":"9307073","id":"PMC_9307073","title":"Expression and function of the early activation antigen CD69 in murine macrophages.","date":"1997","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/9307073","citation_count":45,"is_preprint":false},{"pmid":"35863820","id":"PMC_35863820","title":"Intrahepatic CD69+Vδ1 T cells re-circulate in the blood of patients with metastatic colorectal cancer and limit tumor progression.","date":"2022","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35863820","citation_count":45,"is_preprint":false},{"pmid":"36066993","id":"PMC_36066993","title":"CD69 expression on regulatory T cells protects from immune damage after myocardial infarction.","date":"2022","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/36066993","citation_count":42,"is_preprint":false},{"pmid":"7538976","id":"PMC_7538976","title":"CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapy.","date":"1995","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7538976","citation_count":41,"is_preprint":false},{"pmid":"9116719","id":"PMC_9116719","title":"Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.","date":"1997","source":"Lupus","url":"https://pubmed.ncbi.nlm.nih.gov/9116719","citation_count":40,"is_preprint":false},{"pmid":"29453833","id":"PMC_29453833","title":"Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69.","date":"2018","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29453833","citation_count":39,"is_preprint":false},{"pmid":"18641108","id":"PMC_18641108","title":"Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis.","date":"2008","source":"Chest","url":"https://pubmed.ncbi.nlm.nih.gov/18641108","citation_count":38,"is_preprint":false},{"pmid":"30673129","id":"PMC_30673129","title":"CD69+ memory T lymphocytes of the bone marrow and spleen express the signature transcripts of tissue-resident memory T lymphocytes.","date":"2019","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30673129","citation_count":38,"is_preprint":false},{"pmid":"31928947","id":"PMC_31928947","title":"Increased CD69 expression on activated eosinophils in eosinophilic chronic rhinosinusitis correlates with clinical findings.","date":"2020","source":"Allergology international : official journal of the Japanese Society of Allergology","url":"https://pubmed.ncbi.nlm.nih.gov/31928947","citation_count":37,"is_preprint":false},{"pmid":"11034393","id":"PMC_11034393","title":"Functional analysis of ligand-binding and signal transduction domains of CD69 and CD23 C-type lectin leukocyte receptors.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11034393","citation_count":37,"is_preprint":false},{"pmid":"33548061","id":"PMC_33548061","title":"Implication of CD69+ CD103+ tissue-resident-like CD8+ T cells as a potential immunotherapeutic target for cholangiocarcinoma.","date":"2021","source":"Liver international : official journal of the International Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/33548061","citation_count":35,"is_preprint":false},{"pmid":"12077230","id":"PMC_12077230","title":"Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.","date":"2002","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12077230","citation_count":35,"is_preprint":false},{"pmid":"18003758","id":"PMC_18003758","title":"Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.","date":"2007","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18003758","citation_count":34,"is_preprint":false},{"pmid":"27151919","id":"PMC_27151919","title":"Immune-Regulatory Molecule CD69 Controls Peritoneal Fibrosis.","date":"2016","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/27151919","citation_count":32,"is_preprint":false},{"pmid":"18046548","id":"PMC_18046548","title":"CLEC2A: a novel, alternatively spliced and skin-associated member of the NKC-encoded AICL-CD69-LLT1 family.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/18046548","citation_count":32,"is_preprint":false},{"pmid":"28507790","id":"PMC_28507790","title":"CD69 is a direct HIF-1α target gene in hypoxia as a mechanism enhancing expression on tumor-infiltrating T lymphocytes.","date":"2017","source":"Oncoimmunology","url":"https://pubmed.ncbi.nlm.nih.gov/28507790","citation_count":32,"is_preprint":false},{"pmid":"24668348","id":"PMC_24668348","title":"Human hepatocellular carcinoma-infiltrating CD4⁺CD69⁺Foxp3⁻ regulatory T cell suppresses T cell response via membrane-bound TGF-β1.","date":"2014","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/24668348","citation_count":32,"is_preprint":false},{"pmid":"11328741","id":"PMC_11328741","title":"CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11328741","citation_count":32,"is_preprint":false},{"pmid":"35689672","id":"PMC_35689672","title":"The cellular and molecular basis of CD69 function in anti-tumor immunity.","date":"2022","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35689672","citation_count":31,"is_preprint":false},{"pmid":"7783055","id":"PMC_7783055","title":"Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells.","date":"1995","source":"The Journal of rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/7783055","citation_count":31,"is_preprint":false},{"pmid":"17505822","id":"PMC_17505822","title":"Chicken CD69 and CD94/NKG2-like genes in a chromosomal region syntenic to mammalian natural killer gene complex.","date":"2007","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/17505822","citation_count":31,"is_preprint":false},{"pmid":"30262053","id":"PMC_30262053","title":"Combined CD25, CD64, and CD69 biomarker panel for flow cytometry diagnosis of sepsis.","date":"2018","source":"Talanta","url":"https://pubmed.ncbi.nlm.nih.gov/30262053","citation_count":29,"is_preprint":false},{"pmid":"32528679","id":"PMC_32528679","title":"Synovial fluid CD69+CD8+ T cells with tissue-resident phenotype mediate perforin-dependent citrullination in rheumatoid arthritis.","date":"2020","source":"Clinical & translational immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32528679","citation_count":28,"is_preprint":false},{"pmid":"37892710","id":"PMC_37892710","title":"The Expression of Activation Markers CD25 and CD69 Increases during Biologic Treatment of Psoriasis.","date":"2023","source":"Journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37892710","citation_count":27,"is_preprint":false},{"pmid":"37039481","id":"PMC_37039481","title":"Transmembrane protein CD69 acts as an S1PR1 agonist.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37039481","citation_count":26,"is_preprint":false},{"pmid":"36720287","id":"PMC_36720287","title":"Lung-resident CD69+ST2+ TH2 cells mediate long-term type 2 memory to inhaled antigen in mice.","date":"2023","source":"The Journal of allergy and clinical immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36720287","citation_count":26,"is_preprint":false},{"pmid":"37056775","id":"PMC_37056775","title":"The roles of toll-like receptor 4, CD33, CD68, CD69, or CD147/EMMPRIN for monocyte activation by the DAMP S100A8/S100A9.","date":"2023","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/37056775","citation_count":26,"is_preprint":false},{"pmid":"22389607","id":"PMC_22389607","title":"Human NK Cell Up-regulation of CD69, HLA-DR, Interferon γ Secretion and Cytotoxic Activity by Plasmacytoid Dendritic Cells is Regulated through Overlapping but Different Pathways.","date":"2009","source":"Sensors (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/22389607","citation_count":25,"is_preprint":false},{"pmid":"22096538","id":"PMC_22096538","title":"Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22096538","citation_count":25,"is_preprint":false},{"pmid":"36045683","id":"PMC_36045683","title":"CD69 and SBK1 as potential predictors of responses to PD-1/PD-L1 blockade cancer immunotherapy in lung cancer and melanoma.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36045683","citation_count":24,"is_preprint":false},{"pmid":"31340848","id":"PMC_31340848","title":"CD4+CD69+ T cells and CD4+CD25+FoxP3+ Treg cells imbalance in peripheral blood, spleen and peritoneal lavage from pristane-induced systemic lupus erythematosus (SLE) mice.","date":"2019","source":"Advances in rheumatology (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31340848","citation_count":24,"is_preprint":false},{"pmid":"19383348","id":"PMC_19383348","title":"The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.","date":"2008","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/19383348","citation_count":24,"is_preprint":false},{"pmid":"15893733","id":"PMC_15893733","title":"Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface.","date":"2005","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/15893733","citation_count":23,"is_preprint":false},{"pmid":"15790520","id":"PMC_15790520","title":"Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A.","date":"2004","source":"Immunology letters","url":"https://pubmed.ncbi.nlm.nih.gov/15790520","citation_count":23,"is_preprint":false},{"pmid":"32986791","id":"PMC_32986791","title":"Inverse relationship between oligoclonal expanded CD69- TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients.","date":"2020","source":"Blood advances","url":"https://pubmed.ncbi.nlm.nih.gov/32986791","citation_count":22,"is_preprint":false},{"pmid":"29483712","id":"PMC_29483712","title":"Anti-CD69 therapy induces rapid mobilization and high proliferation of HSPCs through S1P and mTOR.","date":"2018","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/29483712","citation_count":21,"is_preprint":false},{"pmid":"32849474","id":"PMC_32849474","title":"Decreased Expression of CD69 on T Cells in Tuberculosis Infection Resisters.","date":"2020","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/32849474","citation_count":21,"is_preprint":false},{"pmid":"23119065","id":"PMC_23119065","title":"CD69 does not affect the extent of T cell priming.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23119065","citation_count":21,"is_preprint":false},{"pmid":"12818356","id":"PMC_12818356","title":"CD69 expression induced by thapsigargin, phorbol ester and ouabain on thymocytes is dependent on external Ca2+ entry.","date":"2003","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/12818356","citation_count":21,"is_preprint":false},{"pmid":"9767419","id":"PMC_9767419","title":"Expression of CD69 activation marker by endometrial granulated lymphocytes throughout the menstrual cycle and in early pregnancy.","date":"1998","source":"Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9767419","citation_count":21,"is_preprint":false},{"pmid":"29602245","id":"PMC_29602245","title":"Reactive glia promote development of CD103+ CD69+ CD8+ T-cells through programmed cell death-ligand 1 (PD-L1).","date":"2018","source":"Immunity, inflammation and disease","url":"https://pubmed.ncbi.nlm.nih.gov/29602245","citation_count":20,"is_preprint":false},{"pmid":"39694701","id":"PMC_39694701","title":"Personalized neoantigen hydrogel vaccine combined with PD-1 and CTLA-4 double blockade elicits antitumor response in liver metastases by activating intratumoral CD8+CD69+ T cells.","date":"2024","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/39694701","citation_count":20,"is_preprint":false},{"pmid":"11958434","id":"PMC_11958434","title":"CD69 expression on lymphocytes and interleukin-15 levels in synovial fluids from different inflammatory arthropathies.","date":"2002","source":"Rheumatology international","url":"https://pubmed.ncbi.nlm.nih.gov/11958434","citation_count":20,"is_preprint":false},{"pmid":"37223078","id":"PMC_37223078","title":"Unraveling CD69 signaling pathways, ligands and laterally associated molecules.","date":"2023","source":"EXCLI journal","url":"https://pubmed.ncbi.nlm.nih.gov/37223078","citation_count":19,"is_preprint":false},{"pmid":"38768914","id":"PMC_38768914","title":"Integrative analysis discovers Imidurea as dual multitargeted inhibitor of CD69, CD40, SHP2, lysozyme, GATA3, cCBL, and S-cysteinase from SARS-CoV-2 and M. tuberculosis.","date":"2024","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/38768914","citation_count":19,"is_preprint":false},{"pmid":"30947986","id":"PMC_30947986","title":"Detection of culture-negative sepsis in clinical blood samples using a microfluidic assay for combined CD64 and CD69 cell capture.","date":"2019","source":"Analytica chimica acta","url":"https://pubmed.ncbi.nlm.nih.gov/30947986","citation_count":19,"is_preprint":false},{"pmid":"34580321","id":"PMC_34580321","title":"Discovery, optimization and biodistribution of an Affibody molecule for imaging of CD69.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34580321","citation_count":18,"is_preprint":false},{"pmid":"16284445","id":"PMC_16284445","title":"Enhanced expression of CD69 and CD25 antigen on human peripheral blood mononuclear cells by prolactin.","date":"2005","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/16284445","citation_count":18,"is_preprint":false},{"pmid":"11145721","id":"PMC_11145721","title":"Anti-CD69 autoantibodies cross-react with low density lipoprotein receptor-related protein 2 in systemic autoimmune diseases.","date":"2001","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11145721","citation_count":18,"is_preprint":false},{"pmid":"27328704","id":"PMC_27328704","title":"Distinct recirculation potential of CD69+CD103- and CD103+ thymic memory CD8+ T cells.","date":"2016","source":"Immunology and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27328704","citation_count":17,"is_preprint":false},{"pmid":"24975965","id":"PMC_24975965","title":"Increase of CD69, CD161 and CD94 on NK cells in women with recurrent spontaneous abortion and in vitro fertilization failure.","date":"2014","source":"Iranian journal of immunology : IJI","url":"https://pubmed.ncbi.nlm.nih.gov/24975965","citation_count":17,"is_preprint":false},{"pmid":"9626161","id":"PMC_9626161","title":"Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.","date":"1998","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/9626161","citation_count":17,"is_preprint":false},{"pmid":"32890312","id":"PMC_32890312","title":"Evaluating the Timeliness and Specificity of CD69, CD64, and CD25 as Biomarkers of Sepsis in Mice.","date":"2021","source":"Shock (Augusta, Ga.)","url":"https://pubmed.ncbi.nlm.nih.gov/32890312","citation_count":16,"is_preprint":false},{"pmid":"22544938","id":"PMC_22544938","title":"Differential effect of CD69 targeting on bystander and antigen-specific T cell proliferation.","date":"2012","source":"Journal of leukocyte biology","url":"https://pubmed.ncbi.nlm.nih.gov/22544938","citation_count":16,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50005,"output_tokens":7178,"usd":0.128842},"stage2":{"model":"claude-opus-4-6","input_tokens":10989,"output_tokens":4428,"usd":0.248468},"total_usd":0.37731,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1989,\n      \"finding\": \"CD69 cross-linking by mAb induces prolonged elevation of intracellular Ca2+ (mostly via extracellular Ca2+ influx); when PKC is simultaneously activated by PMA, CD69 stimulation drives IL-2 and IFN-γ gene expression, CD25 upregulation, and T cell proliferation; cyclosporin A abolishes these gene expression effects.\",\n      \"method\": \"mAb cross-linking of CD69 on human T cells, Ca2+ flux measurements, cytokine gene expression assays, pharmacological inhibitors (PMA, cyclosporin A)\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal functional assays with defined pharmacological controls, foundational mechanistic study\",\n      \"pmids\": [\"2501389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"CD69 is constitutively expressed on human platelets as a phosphorylated disulfide-linked homodimer; anti-CD69 mAb cross-linking induces platelet aggregation, Ca2+ influx, degranulation (ATP release), and production of thromboxane B2 and PGE2, indicating activation of arachidonic acid metabolism via cyclooxygenase.\",\n      \"method\": \"Biochemical characterization (SDS-PAGE), anti-CD69 mAb stimulation of platelets, Ca2+ influx assay, ATP release assay, thromboxane/PGE2 measurement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal assays with strong mechanistic readouts in a single study\",\n      \"pmids\": [\"2388032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"In neutrophils, CD69 is stored intracellularly (in a trans-Golgi structure, as brefeldin A does not block surface expression but cycloheximide does not inhibit either, since new synthesis is not required) and is rapidly mobilized to the cell surface upon PMA or fMLP activation independent of new protein synthesis; CD69 stimulation in neutrophils induces Ca2+ influx and enhances lysozyme release (granule exocytosis) via a Ca2+-dependent mechanism.\",\n      \"method\": \"Flow cytometry, cycloheximide and brefeldin A pharmacological inhibition, immunoprecipitation, Ca2+ influx assay, lysozyme release assay\",\n      \"journal\": \"Cellular immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple assays in single study, mechanistic conclusions supported by pharmacological inhibitors\",\n      \"pmids\": [\"1586955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD69 cDNA encodes a 199-amino-acid type II transmembrane protein with a C-type lectin-like extracellular domain; the gene maps to chromosome 12p13-p12; its mRNA is rapidly induced and degraded after lymphocyte stimulation due to 3' UTR degradation signals; transient expression of the CD69 cDNA in COS-7 cells reproduced native CD69 properties.\",\n      \"method\": \"PCR-based cDNA cloning, sequence analysis, COS-7 transient expression, somatic cell hybrid DNA analysis and FISH chromosomal mapping\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct molecular cloning with functional validation, highly cited foundational study\",\n      \"pmids\": [\"8340758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"CD69 expression is induced on thymocytes undergoing positive selection only when PKC-dependent signaling is engaged; PKC activator PMA induces CD69 on all thymocytes regardless of selecting MHC ligands, whereas TCR cross-linking induces CD69 only on thymocytes that have undergone or are undergoing positive selection.\",\n      \"method\": \"TCR-transgenic thymocyte cultures, anti-TCR antibody and PMA stimulation, flow cytometry\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — transgenic model plus pharmacological dissection, single study\",\n      \"pmids\": [\"8095460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Constitutively active v-Ha-ras induces CD69 surface expression in Jurkat T cells, and dominant-negative c-Ha-ras-N17 suppresses TCR/CD3-mediated CD69 induction, demonstrating that p21ras activation is required for TCR-mediated CD69 expression.\",\n      \"method\": \"Transfection of constitutively active and dominant-negative ras constructs in Jurkat cells, flow cytometry, ras GTP-loading immunoprecipitation, AP-1-CAT reporter assay\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — gain-of-function and loss-of-function genetic approaches with biochemical validation\",\n      \"pmids\": [\"7907294\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"CD69 gene expression is regulated by the transcription factor AP-1; stimuli that induce AP-1 but not NF-κB upregulate CD69 promoter activity, mRNA, and surface expression; a dominant-negative c-jun abolishes inducible CD69 transcription; an AP-1 binding site at position -16 of the CD69 promoter is transactivated by c-jun expression vectors.\",\n      \"method\": \"CD69 promoter-reporter transfection assays, EMSA, dominant-negative c-jun cotransfection, pharmacological inhibitors (pyrrolidine dithiocarbamate), IκB cotransfection\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (reporter assays, EMSA, dominant-negative), mechanistic dissection of promoter elements\",\n      \"pmids\": [\"9580241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Crystal structure of the C-type lectin-like domain (NKD) of human CD69 was determined in two crystal forms; CD69 NKD adopts the canonical CTLD fold but lacks Ca2+ and carbohydrate binding features; it dimerizes noncovalently through a hydrophobic core with polar interactions including an interdomain β-sheet; a hydrophobic surface patch surrounded by conserved charged residues likely constitutes the ligand-binding site.\",\n      \"method\": \"X-ray crystallography (two crystal forms), solution dimerization analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure with functional interpretation of binding site\",\n      \"pmids\": [\"11036086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD69 engagement activates ERK (a MAPK family member), and this ERK activation is required for CD69-mediated cell degranulation in NK cells; co-engagement of the inhibitory receptor CD94/NKG2-A suppresses both CD69-triggered ERK activation and cell degranulation/cytotoxicity.\",\n      \"method\": \"RBL transfectants co-expressing CD69 and CD94/NKG2-A, ERK phosphorylation assays, degranulation assays, human NK cytotoxicity assays\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted cell system plus primary NK cells, mechanistic inhibitor pathway\",\n      \"pmids\": [\"10671222\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"The cytoplasmic domain of CD69 mediates Ca2+-dependent signaling (dependent on extracellular Ca2+ uptake) and TNF-α production; the neck region (Cys68) is critical for CD69 dimerization; domain swap chimeras between CD69 and CD23 showed that the cytoplasmic domain, not receptor oligomerization, determines the type of signal transduced.\",\n      \"method\": \"CD69/CD23 chimeric receptor domain-swapping, transfection in RBL-2H3 and Jurkat cells, Ca2+ flux assay, serotonin release assay, TNF-α measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-swapping mutagenesis with multiple functional readouts, mechanistic dissection\",\n      \"pmids\": [\"11034393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"CD69 cross-linking in IL-2-activated human NK cells rapidly activates Syk (but not ZAP70) in a Src family kinase (including Lck)-dependent manner; Syk and Src kinases then control tyrosine phosphorylation of PLCγ2 and the Rho GEF Vav1, and together regulate CD69-triggered NK cell cytotoxicity.\",\n      \"method\": \"Anti-CD69 mAb cross-linking, immunoprecipitation, tyrosine phosphorylation assays, kinase activity assays, pharmacological inhibitors, RBL transfectants stably expressing CD69\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple biochemical assays with defined signaling hierarchy in both primary NK cells and transfectants\",\n      \"pmids\": [\"12077230\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Constitutive overexpression of CD69 on T cells throughout development (CD69 transgenic mice) causes accumulation of phenotypically mature thymocytes in the medulla and failure of thymocyte export from the thymus, without affecting T cell maturation or TCR signaling, identifying a role for CD69 in controlling thymocyte egress.\",\n      \"method\": \"CD69 transgenic mouse generation, flow cytometry of thymic subsets, T cell maturation and selection analysis\",\n      \"journal\": \"International immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — transgenic mouse model with clear cellular phenotype, dose-dependent correlation with CD69 surface levels\",\n      \"pmids\": [\"12039905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CD69-deficient mice show enhanced NK cell and T cell anti-tumor responses associated with increased MCP-1 chemokine production, decreased TGF-β production, and decreased lymphocyte apoptosis; CD69 engagement directly induces NK and T cell production of TGF-β, establishing a mechanistic link between CD69 signaling and TGF-β-mediated immunosuppression.\",\n      \"method\": \"CD69-/- mice tumor challenge, adoptive transfer, anti-CD69 antibody treatment in vivo, TGF-β production assays after CD69 engagement\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse model with defined cellular mechanism, direct in vitro mechanistic linkage replicated\",\n      \"pmids\": [\"12732655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Phosphorylation of the actin-bundling protein L-plastin at Ser5 (induced by costimulation via TCR/CD3 plus CD2 or CD28) is required for transport of CD69 (and CD25) to the T cell surface; non-phosphorylatable 5A-L-plastin impairs surface expression of CD69 without affecting total CD69 protein levels.\",\n      \"method\": \"Mass spectrometry identification of phosphorylation site, site-directed mutagenesis of L-plastin (S5A), lentiviral expression in primary T cells, flow cytometry, immunological synapse imaging\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — mass spectrometry plus mutagenesis with clear functional readout, mechanistic dissection of surface transport\",\n      \"pmids\": [\"17294403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CD69 gene transcription in T cells is regulated by evolutionarily conserved non-coding sequences (CNS1-4) upstream of the promoter; these elements function as inducible enhancers (CNS2, CNS4) or suppressors (CNS1, CNS2 together), and together with the promoter enable developmental-stage and lineage-specific regulation of CD69 in T but not B cells.\",\n      \"method\": \"DNase I hypersensitivity mapping, ChIP for histone modifications, transient transfection enhancer assays, transgenic reporter mice\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple complementary approaches (ChIP, transgenic mice, transient transfection), mechanistic dissection of cis-regulatory elements\",\n      \"pmids\": [\"19841192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CD69 associates with S1P1 via its transmembrane and membrane-proximal domains (specifically requiring S1P1 transmembrane helix 4); this interaction suppresses S1P1 function, prolongs S1P binding half-life, and promotes S1P1 internalization and degradation, thereby retaining T cells in lymphoid tissues; a non-S1P1-binding CD69 mutant fails to inhibit T cell egress.\",\n      \"method\": \"Domain swap experiments between CD69 and NKRp1A, S1P1 mutagenesis (glycosylation, sulfation, desensitization motifs, TM helix 4), co-immunoprecipitation, S1P binding half-life assay, in vivo T cell egress assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — domain-mapping mutagenesis with biochemical and in vivo functional validation in a single rigorous study\",\n      \"pmids\": [\"20463015\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The cytoplasmic tail of CD69 associates with the Jak3/Stat5 signaling pathway; CD69 deficiency leads to impaired Jak3/Stat5 activity, reduced RORγt transcription inhibition, and consequently enhanced Th17 differentiation; selective Jak3 inhibition enhances RORγt transcription, and exogenous IL-2 restores Stat5 phosphorylation and suppresses enhanced Th17 differentiation in CD69-deficient cells.\",\n      \"method\": \"CD69-/- mouse T cell differentiation assays, biochemical co-immunoprecipitation of CD69 cytoplasmic tail with Jak3/Stat5, Stat5 phosphorylation assays, Jak3 inhibitor experiments, IL-2 rescue experiments, RORγt mRNA quantitation\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical interaction plus functional rescue experiments with multiple orthogonal readouts\",\n      \"pmids\": [\"20696842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CD69-deficient effector CD4 T cells fail to relocate into and persist in the bone marrow, and consequently fail to differentiate into resting memory Th cells; this leads to defective generation of high-affinity antibodies and bone marrow long-lived plasma cells, establishing a role for CD69 in memory Th cell formation and bone marrow homing.\",\n      \"method\": \"CD69-/- mouse immunization models, flow cytometry of bone marrow T cell subsets, antibody affinity measurement, ELISPOT for plasma cells\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CD69-/- mouse model with multiple defined cellular and humoral immune readouts\",\n      \"pmids\": [\"22474373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Galectin-1 on dendritic cells is a natural ligand for CD69; CD69 binds galectin-1 in a direct, carbohydrate-dependent interaction as confirmed by surface plasmon resonance and anti-CD69 blocking; this CD69-galectin-1 interaction mediates the negative effect of galectin-1 on Th17 differentiation in both human and mouse T cells.\",\n      \"method\": \"Recombinant CD69 extracellular domain pulldown on dendritic cells followed by mass spectrometry, surface plasmon resonance, anti-CD69 blocking assays, Th17 differentiation functional assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — pulldown-MS identification plus SPR binding characterization plus functional validation\",\n      \"pmids\": [\"24752896\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CD69 surface expression by skin-infiltrating CD8 T cells (regulated by local antigen stimulation and type I IFNR signaling) coincides with transcriptional downregulation of S1P1; CD69 expression, by interfering with S1P1 function, is a critical determinant of prolonged T cell retention and local TRM formation in skin.\",\n      \"method\": \"Skin-resident T cell transfer models, flow cytometry, transcriptional analysis of S1P1, in vivo T cell retention assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model with mechanistic pathway placement (CD69→S1P1 suppression→tissue retention)\",\n      \"pmids\": [\"25624457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CD69 associates with the S100A8/S100A9 heterodimer (identified by co-immunoprecipitation and mass spectrometry); this interaction is glycosylation-dependent (N-linked glycans including sialic acid on CD69 are required); CD69-S100A8/S100A9 association upregulates SOCS3, thereby inhibiting STAT3 signaling and supporting TGF-β secretion and regulatory T cell differentiation.\",\n      \"method\": \"Immunoprecipitation and mass spectrometry, glycomics analysis of CD69, competition assay, PNGase F treatment, RNA interference, STAT3 signaling assays, Treg differentiation assays\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple biochemical approaches in single lab; mechanistic pathway from ligand binding to signaling outcome\",\n      \"pmids\": [\"26296369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CD69 associates with the aromatic amino acid transporter complex LAT1-CD98 (SLC7A5-SLC3A2) on the surface of γδ T cells and regulates its surface expression and L-tryptophan uptake; this controls intracellular L-Trp-derived AhR activators, leading to AhR-dependent IL-22 secretion and skin inflammation in psoriasis.\",\n      \"method\": \"Co-immunoprecipitation of CD69 with LAT1-CD98, flow cytometry of LAT1-CD98 surface expression in CD69-/- vs WT γδ T cells, L-Trp uptake assays, AhR inhibitor and IL-22 neutralization experiments, CD69-/- mouse IL-23-induced psoriasis model\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — co-IP interaction plus functional metabolic assay plus in vivo rescue experiments with multiple pharmacological agents\",\n      \"pmids\": [\"27376471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HIF-1α directly transactivates the CD69 gene through a hypoxia response element (HRE) in the human CD69 locus; T cells in hypoxic conditions or hypoxic tumor microenvironments upregulate CD69 mRNA and protein in a HIF-1α-dependent manner.\",\n      \"method\": \"ChIP demonstrating HIF-1α binding to CD69 HRE, HIF-1α inducible knockout T cells, pimonidazole hypoxia labeling in vivo, quantitative RT-PCR and flow cytometry under hypoxia\",\n      \"journal\": \"Oncoimmunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP plus genetic HIF-1α KO validation plus in vivo hypoxia tracking\",\n      \"pmids\": [\"28507790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD69 overexpression in Tregs stimulates higher IL-10 production through STAT3 and STAT5 signaling pathways, with STAT3 directly binding the c-Maf promoter to drive c-Maf-dependent IL-10 expression; CD69+ Tregs but not CD69- Tregs or IL-10-deficient CD69+ Tregs prevent inflammatory bowel disease development after adoptive transfer.\",\n      \"method\": \"CD69 overexpression in Tregs, STAT3/STAT5 siRNA silencing, ChIP demonstrating STAT3 binding to c-Maf promoter, adoptive transfer into IBD mouse model, IL-10 ELISA\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus siRNA plus adoptive transfer, single lab study\",\n      \"pmids\": [\"30185773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CD69 targeting with anti-CD69 mAb induces rapid mobilization of bone marrow leukocytes (including hematopoietic stem and progenitor cells) through S1P-dependent mechanisms (blocked by FTY720), and this mobilization is accompanied by increased mTOR/p70S6K/S6/4E-BP1 phosphorylation; mTOR inhibition with rapamycin blocks anti-CD69-induced HSPC mobilization.\",\n      \"method\": \"In vivo anti-CD69 mAb treatment, FTY720 blockade, AMD3100 comparison, flow cytometry of HSPC subsets, phosphorylation assays of mTOR pathway components, rapamycin inhibition\",\n      \"journal\": \"Leukemia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo mouse model with pharmacological dissection of S1P and mTOR pathways, single lab\",\n      \"pmids\": [\"29483712\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CD69 expression on Tregs promotes AhR-dependent CD39 ectonucleotidase activity, which induces apoptosis of γδ T cells and decreases their IL-17A production; in CD69-/- mice after myocardial infarction, enhanced IL-17+ γδT cell responses worsen cardiac function; adoptive transfer of CD69+ Tregs into CD69-/- mice reduces IL-17+ γδT cell recruitment and increases survival.\",\n      \"method\": \"Cd69-/- mouse LAD ligation model, AhR inhibitor experiments, adoptive transfer of CD69+ Tregs, flow cytometry, CD39 ectonucleotidase activity assays, apoptosis assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — knockout mouse model with mechanistic pathway (CD69→AhR→CD39→γδT apoptosis) validated by adoptive transfer and enzyme activity assays\",\n      \"pmids\": [\"36066993\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Cryo-EM structure of CD69-bound S1PR1 coupled to heterotrimeric Gi reveals that the transmembrane helix of one CD69 homodimer protomer contacts S1PR1-TM4; this interaction allosterically induces movement of S1PR1-TM5-6, directly activating the receptor and engaging Gi; CD69 thus acts as a protein agonist (in cis) of S1PR1, promoting Gi-dependent S1PR1 internalization, loss of S1P gradient sensing, and inhibition of lymphocyte egress. Key interface mutations reduce CD69-S1PR1 interaction and receptor internalization.\",\n      \"method\": \"Cryo-EM structure determination of CD69-S1PR1-Gi complex, mutagenesis of interface residues, receptor internalization assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with mutagenesis and functional validation, definitive mechanism\",\n      \"pmids\": [\"37039481\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CD69 associates with an N-terminal fragment of calreticulin expressed at the surface of human PBMCs, as identified by co-immunoprecipitation followed by direct protein sequencing (LC/MS/MS).\",\n      \"method\": \"Co-immunoprecipitation and LC/MS/MS protein sequencing from primary human PBMCs\",\n      \"journal\": \"Archives of biochemistry and biophysics\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP/MS identification without functional follow-up validation\",\n      \"pmids\": [\"15893733\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CD69 is a type II C-type lectin-like homodimeric receptor (crystal/cryo-EM structure resolved) that, upon activation, signals through PKC→Ras→ERK and Src→Syk→PLCγ2/Vav1 pathways to drive Ca2+ influx, cytokine gene expression (IL-2, IFN-γ, TNF-α), and TGF-β production; its cytoplasmic tail associates with Jak3/Stat5 to suppress Th17 differentiation; it physically associates in cis with S1PR1 (via TM helix contacts) to act as a GPCR protein agonist that drives Gi-dependent S1PR1 internalization and degradation, thereby retaining lymphocytes in tissues; it also associates with the amino acid transporter LAT1-CD98 to regulate L-tryptophan uptake and AhR-dependent IL-22 secretion, and binds extracellular ligands galectin-1 and S100A8/S100A9 to modulate Th17 and Treg differentiation respectively; HIF-1α directly transactivates CD69 transcription through an HRE, while AP-1 and NF-κB regulate its promoter, and L-plastin phosphorylation controls CD69 surface transport.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CD69 is a type II C-type lectin-like homodimeric receptor that functions as a central regulator of lymphocyte tissue retention, activation signaling, and immunomodulatory cytokine production. Structurally, CD69 dimerizes through its extracellular C-type lectin-like domain and uses its transmembrane helix to engage S1PR1 in cis, acting as a protein agonist that activates Gi-coupled S1PR1 internalization and degradation, thereby abolishing S1P-directed lymphocyte egress and enforcing tissue residency [PMID:20463015, PMID:37039481]. Upon cross-linking, CD69 signals through its cytoplasmic tail via Src→Syk→PLCγ2/Vav1 and Ras→ERK pathways to drive Ca²⁺ influx, cytokine gene expression (IL-2, IFN-γ, TNF-α), and TGF-β production, while also associating with Jak3/Stat5 to suppress Th17 differentiation by inhibiting RORγt transcription [PMID:2501389, PMID:12077230, PMID:20696842, PMID:12732655]. CD69 additionally interacts with extracellular ligands galectin-1 and S100A8/S100A9 to regulate Th17 and Treg differentiation, and associates with the LAT1-CD98 amino acid transporter to control L-tryptophan uptake and AhR-dependent IL-22 secretion [PMID:24752896, PMID:26296369, PMID:27376471].\",\n  \"teleology\": [\n    {\n      \"year\": 1989,\n      \"claim\": \"Establishing that CD69 is a signaling receptor: cross-linking demonstrated that CD69 transduces Ca²⁺ influx and, when PKC is co-activated, drives cytokine gene expression (IL-2, IFN-γ) in a calcineurin-dependent manner, defining it as a functional activating receptor on T cells.\",\n      \"evidence\": \"Anti-CD69 mAb cross-linking on human T cells with Ca²⁺ flux measurement, cytokine assays, and cyclosporin A inhibition\",\n      \"pmids\": [\"2501389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Proximal signaling intermediates downstream of cross-linking were not identified\", \"Whether CD69 signals autonomously or requires co-receptors was unresolved\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Extending CD69 function beyond lymphocytes: CD69 was shown to be constitutively expressed on platelets as a disulfide-linked homodimer, where its cross-linking induced aggregation, Ca²⁺ influx, degranulation, and arachidonic acid metabolite production, establishing it as a functional activating receptor in non-lymphoid hematopoietic cells.\",\n      \"evidence\": \"Anti-CD69 mAb stimulation of human platelets with SDS-PAGE, Ca²⁺ flux, ATP release, and thromboxane/PGE2 measurement\",\n      \"pmids\": [\"2388032\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Platelet CD69 ligand identity was unknown\", \"Whether intracellular signaling pathways differ from lymphocytes was not tested\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Defining CD69 molecular identity and linking its induction to positive selection: cDNA cloning revealed a 199-aa type II transmembrane protein with a C-type lectin-like domain on chromosome 12p; concurrently, CD69 induction during thymic selection was shown to require PKC-dependent signaling.\",\n      \"evidence\": \"PCR-based cDNA cloning with COS-7 expression; TCR-transgenic thymocyte stimulation with PMA and anti-TCR, flow cytometry\",\n      \"pmids\": [\"8340758\", \"8095460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD69 is functionally required for selection or merely a marker was unclear\", \"No structural data on the lectin domain\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Placing Ras in the TCR-to-CD69 signaling axis: constitutively active v-Ha-ras induced CD69, while dominant-negative ras blocked TCR-mediated CD69 expression, establishing p21ras as an essential node upstream of CD69 transcription.\",\n      \"evidence\": \"Gain- and loss-of-function ras constructs in Jurkat cells, flow cytometry, ras GTP-loading assays\",\n      \"pmids\": [\"7907294\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream transcription factors linking ras to CD69 promoter were not identified in this study\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying AP-1 as a direct transcriptional regulator of CD69: an AP-1 site at position −16 in the CD69 promoter was shown to be transactivated by c-Jun, and dominant-negative c-Jun abolished inducible CD69 transcription, connecting the Ras/MAPK pathway to CD69 gene expression.\",\n      \"evidence\": \"CD69 promoter-reporter assays, EMSA, dominant-negative c-Jun cotransfection in T cells\",\n      \"pmids\": [\"9580241\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of NF-κB sites to CD69 promoter regulation under other conditions was not fully resolved\", \"Chromatin context was not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Resolving the structural basis of the CD69 ectodomain and dissecting signaling domains: crystal structure showed the CTLD fold lacks canonical Ca²⁺/carbohydrate-binding features; concurrently, domain-swap chimeras demonstrated that the cytoplasmic tail (not receptor oligomerization) determines signaling output, while ERK activation was identified as required for CD69-mediated NK cell degranulation.\",\n      \"evidence\": \"X-ray crystallography of CD69 CTLD; CD69/CD23 chimeric receptors in RBL/Jurkat cells; ERK phosphorylation and degranulation assays in NK cells\",\n      \"pmids\": [\"11036086\", \"11034393\", \"10671222\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Natural ligand identity remained unknown\", \"How the short cytoplasmic tail engages signaling mediators was not determined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Defining the proximal signaling cascade and revealing a role in thymocyte egress: Src-family kinase–dependent Syk activation (not ZAP70) was identified as the proximal pathway linking CD69 cross-linking to PLCγ2/Vav1 phosphorylation and NK cytotoxicity; simultaneously, CD69 transgenic mice showed that constitutive CD69 expression blocks thymocyte export without affecting maturation.\",\n      \"evidence\": \"Anti-CD69 mAb cross-linking with kinase assays and pharmacological inhibitors in NK cells; CD69-transgenic mouse thymic analysis\",\n      \"pmids\": [\"12077230\", \"12039905\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which CD69 blocks egress was unknown\", \"Whether Syk activation occurs in T cells as well as NK cells was not shown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing CD69 as an immunosuppressive regulator through TGF-β: CD69-deficient mice showed enhanced anti-tumor immunity due to reduced TGF-β production and increased MCP-1; direct CD69 engagement induced TGF-β secretion by NK and T cells, revealing an immunoregulatory signaling output.\",\n      \"evidence\": \"CD69−/− mice tumor challenge, adoptive transfer, in vitro CD69 engagement with TGF-β measurement\",\n      \"pmids\": [\"12732655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TGF-β induction requires specific signaling intermediates was not resolved\", \"Identity of endogenous CD69 ligand triggering TGF-β remained unknown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identifying a cytoskeletal checkpoint for CD69 surface delivery: L-plastin phosphorylation at Ser5 was required for CD69 transport to the T cell surface, revealing post-translational control of CD69 surface expression independent of transcription.\",\n      \"evidence\": \"Mass spectrometry of L-plastin phosphorylation, S5A mutagenesis, lentiviral expression in primary T cells, flow cytometry\",\n      \"pmids\": [\"17294403\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether L-plastin directly binds CD69-containing vesicles or acts indirectly through actin remodeling was not determined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Solving the molecular mechanism of lymphocyte tissue retention: CD69 was shown to associate with S1PR1 via transmembrane contacts (requiring S1PR1-TM4), promoting S1PR1 internalization and degradation; simultaneously, CD69's cytoplasmic tail was found to engage Jak3/Stat5, suppressing RORγt and Th17 differentiation.\",\n      \"evidence\": \"Domain-swap and TM4 mutagenesis with co-IP and in vivo egress assays; CD69−/− T cell Jak3/Stat5 biochemistry with IL-2 rescue\",\n      \"pmids\": [\"20463015\", \"20696842\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the CD69–S1PR1 interface was lacking\", \"Whether Jak3/Stat5 association is direct or mediated by an adaptor was not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying the first natural extracellular ligands: galectin-1 on dendritic cells was identified as a carbohydrate-dependent CD69 ligand that mediates suppression of Th17 differentiation, establishing a receptor-ligand axis for CD69's immunomodulatory function.\",\n      \"evidence\": \"Recombinant CD69 pulldown from DCs followed by mass spectrometry, SPR binding, blocking antibodies, Th17 differentiation assays\",\n      \"pmids\": [\"24752896\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding affinity and stoichiometry were not fully characterized\", \"Whether galectin-1 binding triggers the same intracellular pathways as antibody cross-linking was not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Extending the ligand repertoire and demonstrating tissue-resident memory formation: S100A8/S100A9 was identified as a glycosylation-dependent CD69 ligand that signals via SOCS3/STAT3 to promote Treg differentiation; CD69 expression on skin CD8 T cells was shown to be essential for tissue-resident memory (TRM) formation via S1PR1 suppression.\",\n      \"evidence\": \"Co-IP/MS identification of S100A8/S100A9, glycomics, STAT3 signaling assays; skin T cell transfer with S1PR1 transcriptional analysis\",\n      \"pmids\": [\"26296369\", \"25624457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of glycan-dependent S100A8/S100A9 binding was unknown\", \"Whether S100A8/S100A9 and galectin-1 compete for the same binding site was not addressed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Revealing a metabolic function: CD69 was found to associate with the LAT1-CD98 amino acid transporter, controlling its surface expression and L-tryptophan uptake, which feeds AhR activation and IL-22 secretion in γδ T cells driving psoriatic inflammation.\",\n      \"evidence\": \"Co-IP of CD69 with LAT1-CD98, L-Trp uptake assays in CD69−/− vs WT γδ T cells, AhR inhibitor and IL-22 neutralization, CD69−/− psoriasis model\",\n      \"pmids\": [\"27376471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD69–LAT1 interaction is direct or mediated by CD98 was not determined\", \"Relevance beyond γδ T cells was not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Adding hypoxia-responsive transcriptional control: HIF-1α was shown to directly transactivate CD69 through an HRE, explaining CD69 upregulation in hypoxic tumor microenvironments and providing a mechanism for hypoxia-driven lymphocyte tissue retention.\",\n      \"evidence\": \"ChIP for HIF-1α at CD69 HRE, conditional HIF-1α knockout T cells, pimonidazole labeling in vivo\",\n      \"pmids\": [\"28507790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of HIF-1α vs AP-1 in tumor contexts was not quantified\", \"Whether HIF-1α-induced CD69 mediates S1PR1 internalization specifically in tumors was not tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Connecting CD69 to ectonucleotidase-mediated immunosuppression: CD69 on Tregs was shown to promote AhR-dependent CD39 activity, inducing γδ T cell apoptosis and reducing IL-17A production; this pathway is cardioprotective after myocardial infarction.\",\n      \"evidence\": \"CD69−/− mouse LAD ligation, AhR inhibitor, adoptive transfer of CD69+ Tregs, CD39 activity assays, apoptosis assays\",\n      \"pmids\": [\"36066993\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CD69 directly activates AhR or acts through tryptophan metabolite changes was not distinguished\", \"Relevance to other tissue injury models was not tested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Providing atomic-resolution proof that CD69 is a GPCR protein agonist: cryo-EM of the CD69–S1PR1–Gi complex revealed that one CD69 TM helix contacts S1PR1-TM4, allosterically displacing TM5-6 to activate Gi coupling, definitively establishing the structural mechanism of CD69-mediated S1PR1 internalization and lymphocyte retention.\",\n      \"evidence\": \"Cryo-EM structure determination of CD69–S1PR1–Gi ternary complex, interface mutagenesis, receptor internalization assays\",\n      \"pmids\": [\"37039481\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the second CD69 protomer in the homodimer can simultaneously engage another S1PR1 molecule is unknown\", \"The structure was obtained in detergent — lipid bilayer effects on the interface remain untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include whether CD69's multiple cis-membrane partners (S1PR1, LAT1-CD98) can be simultaneously engaged, how the short cytoplasmic tail recruits both Jak3/Stat5 and Syk/PLCγ2 pathways in different cell types, and whether additional physiological soluble ligands exist beyond galectin-1 and S100A8/S100A9.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No reconstitution of simultaneous CD69–S1PR1 and CD69–LAT1 complexes\", \"Structural basis of cytoplasmic tail signaling selectivity is unknown\", \"Comprehensive ligand screening has not been performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [15, 16, 26]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 9, 10]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [21, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 3, 13, 21]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 10, 12, 16, 18, 21, 25]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [5, 8, 15, 16, 26]},\n      {\"term_id\": \"R-HSA-109582\", \"supporting_discovery_ids\": [1]}\n    ],\n    \"complexes\": [\n      \"CD69 homodimer\",\n      \"CD69-S1PR1-Gi complex\"\n    ],\n    \"partners\": [\n      \"S1PR1\",\n      \"LGALS1\",\n      \"S100A8\",\n      \"S100A9\",\n      \"SLC7A5\",\n      \"SLC3A2\",\n      \"JAK3\",\n      \"SYK\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}